Digoxin‐like Immunoreactive Substance and Sodium‐Potassium‐Adenosine Triphosphatase Inhibition in Normal PregnancyA Longitudinal Study
作者:
GEORGE GILSON,
STEVEN GRAVES,
CLIFFORD QUALLS,
LUIS CURET,
期刊:
Obstetrics & Gynecology
(OVID Available online 1997)
卷期:
Volume 89,
issue 5, Part 1
页码: 743-746
ISSN:0029-7844
年代: 1997
出版商: OVID
数据来源: OVID
摘要:
ObjectiveTo measure the levels of digoxin-like immunoreactive substance and digitalis-like factor bioactivity as manifested by sodium-potassium-adenosine triphosphatase (ATPase) inhibition throughout pregnancy.MethodsSerum samples were collected from primigravidas in early (15 ± 1.8 weeks), mid (26 ± 1.2 weeks), and late (36 ± 1.1 weeks) gestation, as well as at 6 ± 1.1 weeks postpartum (mean ± standard error). Digoxin-like immunoreactive substance levels were determined by radioimmuno-assay and digitalis-like factor bioactivity was determined by inhibition of ATPase. Data were analyzed by means of repeated measures analysis of variance.ResultsIn 41 women with normal pregnancy outcomes, levels of digoxin-like immunoreactive substance rose progressively and significantly (P< .001) throughout pregnancy and returned to normal levels postpartum. Inhibition of ATPase activity also rose significantly (P< .004), but not as dramatically, during pregnancy and remained elevated 6 weeks postpartum.ConclusionAlthough digoxin-like immunoreactive substance levels rise in pregnancy, functional digitalis-like factor activity, as manifested by inhibition of ATPase, does not parallel this rise strictly, implying that digoxin-like immunoreactive substance receptors may be reset during normal pregnancy. The enhanced cardiac performance that occurs in normal pregnancy may be mediated in part by increased digitalis-like factor activity.
点击下载:
PDF
(290KB)
返 回